aged patients with heart failure 老年心功能不全
elderly patients with heart failure 老年心力衰竭患者
hospitalized patients with heart failure 心力衰竭住院患者
Patients with congestive heart failure 充血性心力衰竭
patients with heart-lung failure 心肺功能衰竭患者
patients with chronic heart failure 慢性心力衰竭患者
Therefore, it may be of value in the treatment of patients with heart failure.
因此,它在治疗心力衰竭的病人上可能有其独特的价值。
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
正五聚蛋白3,一个新的血管炎症因子,预示着心力衰竭患者的不良预后。
The plasma PTX3 level provides important prognostic information for the risk stratification of patients with heart failure.
血清ptx3水平为心力衰竭患者危险分层提供了重要的预后信息。
应用推荐